Phenylarsine oxide (PAO), a trivalent arsenical, has been shown to inhibit insulin-stimulated glucose transport in 3T3-LI adipocytes, implicating vicinal dithiols in signal transmission [Frost & Lane (1985 ) J. Biol. Chem. 260, 2646-2652. To assist in the direct identification of a PAO-binding protein which might be involved in this process, we have synthesized [3H]acetylaminophenylarsine oxide ([3H]APAO) from the amino derivative of phenylarsine oxide (NPAO). To assess the inhibitory effect of the product, a dual-labelling experiment was performed which showed that [3H]APAO inhibited insulin-stimulated 2-deoxy[l-14C]glucose transport in 3T3-L1 adipocytes with a K1 of 21 /uM, identical with that of the parent compound, NPAO. Further characterization revealed that over a wide concentration range, uptake of the labelled arsine oxide was linear. Although the dithiol reagent 2,3-dimercaptopropanol (DMP) reversed PAO-induced inhibition of transport, it had no effect on the uptake of [3H]APAO. In a simple fractionation experiment approx. 50% of the radioactivity was associated with the cytosolic fraction and 50% with the total membrane fraction. Identification of radiolabelled proteins by non-reducing SDS/PAGE revealed fraction-specific binding, although many proteins were observed. Covalent modification was time-dependent and could be reversed by addition of DMP. These data further support a role for vicinal dithiols in insulin-stimulated glucose transport. Additionally, the probe described may offer a new means with which to identify the inhibitory protein or, more globally, to investigate mechanisms of action of vicinal dithiol-containing proteins.
INTRODUCTION
It has been known for many years that insulin stimulates the rate of glucose transport in specific target tissues. Both the insulin receptor (the f-subunit) (Ebina et al., 1985) and the glucose transporter (Mueckler et al., 1985) are integral proteins of the membrane. Although the signalling event between the two proteins is not known, it has been proposed that stimulation of transport activity by insulin may occur by recruitment of transporters to the cell surface (translocation) (Cushman & Wardzala, 1980; Suzuki & Kono, 1980) and/or by intrinsic activation (Baly & Horuk, 1987; Kahn & Cushman, 1987; Joost et al., 1988; Blok et al., 1988; Calderhead & Lienhard, 1988) . It has been further suggested that autophosphorylation of the insulin receptor and subsequent activation of the tyrosine kinase play a role in signal transmission Ellis et al., 1986) . Of potential importance is the observation that phenylarsine oxide (PAO) inhibits insulin-stimulated glucose transport (but not basal transport) in 3T3-L1 adipocytes (Frost & Lane, 1985) . This inhibition could be reversed by 2,3-dimercaptopropanol (DMP) but not mercaptoethanol (MCE), suggesting the involvement of vicinal dithiols. Further experiments indicated that PAO interfered with post-receptor signalling, since neither insulin binding (Frost & Lane, 1985) nor receptor tyrosine kinase activity (Frost et al., 1987) were affected by the arsenical. However, PAO did inhibit certain insulinstimulated serine-specific phosphorylation events in intact cells (Frost et al., 1987) . One interpretation of this latter observation is that the activated insulin receptor stimulates the activity of a serine kinase. Other experiments have been presented which support the existence of such a cascade (Czech et al., 1988; Ray & Sturgill, 1988) . However, other data also suggest that PAO may block a tyrosine-specific phosphatase (Bernier et al., 1987) , perhaps inhibiting the turnover of a signal molecule.
With PAO covalently attached to a resin, preliminary data suggested that PAO must enter the cell to elicit inhibition (Saylor & Frost, 1989) . Thus the goals of this study were to synthesize a labelled arsenical, to characterize its uptake into 3T3-LI adipocytes, and to identify PAO-binding proteins. This information would provide the basis for future identification of the PAO-sensitive target in insulin-stimulated glucose transport, a step toward understanding how insulin functions inside the cell.
EXPERIMENTAL Acetylation of para-aminophenylarsine oxide
The synthesis of aminophenylarsine oxide (NPAO) has been described (Stevenson et al., 1978) . The acetylation reaction was performed in a vented hood. The reaction vessel containing [3H]acetic anhydride (9.5Ci/mmol; 2.63 ,umol/25 mCi) was capped with a serum stopper so that additions could be made through the septum. The bottom of the vessel was cooled in solid CO2 to condense the acetic anhydride. The seal was broken and 2.5 ,cmol of NPAO, dissolved in 100 4u1 of anhydrous acetone, was injected into the reaction chamber. The vessel was brought to room temperature and allowed to sit for 60 min, with mixing every 15 min. Unlabelled acetic anhydride (10 ,mol, in 
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(v/v) solution of water/95 % ethanol. The final specific radioactivity was approx. 600 ,Ci/,umol of acetylaminophenylarsine oxide ([3H]APAO), determined as described below.
Determination of specific activity
To determine the concentration of recovered APAO in the above synthesis, a standard curve was generated using a modification of Ellman's procedure (Ellman, 1959) . For each assay, 120 nmol of DMP was mixed with 3 ml of 20 mmphosphate buffer, pH 8.0, just before analysis. Various concentrations of PAO (0-80 nmol) or [3H]APAO were then added to appropriate tubes, each containing 3 ml of the DMP solution. After 5 min, 250 nmol of DTNB [5,5'-dithiobis-(2-nitro)benzoic acid] was added to each tube and mixed immediately. The absorbance of the [3H]APAO samples was read at 412 nm and compared with the known values for PAO.
Cell culture and deoxyglucose transport
The details of differentiation and transport have been documented elsewhere (Frost & Lane, 1985 3T3-L1 adipocytes were incubated in serum-free medium for 2 h in a CO2 incubator. The cells were then washed three times with 3.0 ml of Krebs-Ringer phosphate buffer, pH 7.4 (KRP). The cells were incubated in 1.0 ml of KRP with or without 1 ,UMinsulin for 10 min at 37 'C. Following this, the cells were incubated with various concentrations of [3H]APAO in the presence or absence of 400 ,tM-DMP for the indicated times. The cells were then' washed with 3 x 3.0 ml of ice-cold phosphatebuffered saline (PBS; 120 mM-NaCI/2.7 mM-KCI/10 mM-sodium phosphate, pH 7.4) and homogenized either in 0.5 ml of TES (Tris, 10 mM; EDTA, I mM; sucrose, 250 mM; pH, 7.3) for subcellular fractionation or in 0.5 ml of SDS (0.1 %) for nonfractionated samples. The TES homogenate was centrifuged at 212 000 g for 70 min at 4 'C. The supernatant (cytosolic fraction) was removed and the pellet (membrane fraction) was resuspended in 0.5 ml of TES. A portion of each fraction was assayed for radioactivity or was mixed with sample dilution buffer (Laemmli, 1970) and run on a 12.5 % non-reducing SDS/polyacrylamide gel. Before drying, the gels were incubated in 1 M-salicylic acid for 1 h. The dried gels were exposed to pre-flashed film for 7 days. When appropriate, lanes were analysed by laser densitometry.
Labelling of proteins in vitro Cells were treated as described above with or without insulin for 10 min. The cells were then homogenized in 0. 
RESULTS

Effect of arsenicals on insulin-stimulated deoxyglucose transport
As shown earlier (Frost & Lane, 1985) and verified here, PAO effectively blocked insulin-stimulated glucose transport (K, 9 ,uM) ( Fig. la) . Since a derivative of this arsenical was to be used for radiolabelling and subsequent identification of binding protein(s), it was necessary to demonstrate its effectiveness in the transport assay. Accordingly, we show in Fig. l (a) that NPAO inhibited insulin-stimulated transport in a manner similar to PAO, although the curve was shifted to the right (K1 21 #M).
Unlabelled APAO (synthesized as described in the Experimental section but using unlabelled acetic anhydride) gave similar results.
Using a dual-labelling procedure we then monitored the effect of 
Uptake of I3HIAPAO
Since the labelled arsenical inhibited insulin-stimulated transport as did the parent compound, we then determined celldependent uptake (association) of the radiolabelled PAO. Over a wide range ofconcentrations the uptake ofthe labelled arsenical was linear (Fig. 1 c) . At each concentration, approx. 8 % of the added radioactivity was taken up during the 30 min incubation. Approx. 90 % of the cell-associated label could be precipitated with trichloroacetic acid.
When cells were preincubated with insulin to first activate transport followed by NPAO addition, we were able to determine the minimum time required for arsenical action. As shown in Fig.  2 , inhibition of insulin-stimulated transport could be seen within 2.5 min of NPAO addition, although the half-time was 10 min (inset). The association of labelled arsenical also appeared to be time-dependent, ultimately reaching a steady-state plateau (Fig.  3a) . The half-time for association was 10 min, identifical to that for inhibition from the stimulated state. Because the association data suggested exchange between the cell and extracellular buffer, we also measured the efflux of [3H]APAO (Fig. 3b) . As can be seen, cell-associated radioactivity fell to a steady level as [3H]APAO was released from 'pre-loaded' cells into the buffer.
Thus there was a cell-associated pool or compartment (about 30% of the associated label) that prevented and/or reversed the inhibition of insulin-stimulated glucose transport by PAO (Frost & Lane, 1985) . This was also true for NPAO-induced inhibition, as shown in Fig. 4(a) . Despite its ability to reverse inhibition, DMP had no effect on the association of radiolabelled arsenical to whole cells ( Fig. 4b and Table 1 ). This suggests that the hydrophobic character of the arsenical rather than its interaction with dithiols dictates physical location. Unlike DMP, MCE was ineffective in reversing inhibition (Fig. 4a) . However, MCE enhanced association by 4-fold (Fig. 4b) presumably because of non-specific interaction of the labelled arsenical with free thiols which are exposed upon reduction of oligomeric proteins.
Compartmentation of 13HIAPAO
To identify the subcellular compartment to which the labelled arsenical associates, a simple fractionation was performed. After incubation with [3H]APAO for 30 min in the absence or presence of insulin, the cells were washed, homogenized and separated by 100 centrifugation into membrane and cytosolic fractions. Assay of these fractions revealed that 52 % of the radioactivity was associated with the membranes, while a surprising 48 % was associated with the cytosol (Table 1 ). The fractions were analysed by non-reducing SDS/PAGE. The cytosolic fraction contained at least ten labelled proteins, ranging in molecular mass from 13 kDa to 95 kDa, several of which were unique to this fraction (including 13.9 kDa, 15.4 kDa, 36 kDa) (Fig. 5) When cells were preincubated for 10 min with NPAO and then assayed in the presence of insulin and DMP, inhibition of transport was quickly reversed (Fig. 6a) . A corresponding experiment was performed with [3H]APAO to follow proteinspecific binding and its reversal by DMP. Figure 6 Cells were preincubated for 10 min with 1 /M-insulin. NPAO (50 sM) was added and transport was measured for 2.5 min intervals at various times thereafter. The inset shows the same data plotted on a log scale for half-time determination. A, Basal; *, insulinstimulated; *, insulin plus NPAO.
analogous to the experiment with NPAO described in Fig. 6 Fig. 7(a) . The upper trace reveals that ten major proteins were labelled by the arsenical after 10 min of preincubation (see legend for molecular masses). At 5 min after addition of DMP (lower trace), label remained only in proteins 1, 6, 9 and 10, which may be resistant to DMP because of inaccessibility, by virtue of either structure or compartmentation. addition, more than 90 % of the protein-associated radioactivity was lost (Fig. 7c ), which correlates with the immediate recovery of transport stimulation in the presence of DMP (Fig. 6a) . From these data, we conclude that binding of [3H]APAO (and thus inhibition) was dependent on the interaction of the arsenical with proteins but reduces redox vicinal sulphydryls (Webb, 1966 (Knutson et al., 1983) which serve as the control cell )onding to 13.9 kDa (1), 15.4 kDa line for 3T3-LI adipocytes. However, it is unclear whether ikDa (5), 36 kDa (6), 40 kDa (7), insulin receptor internalization is required for activation of la (10). Only four proteins could be intracellular events. e) corresponding to 13.9 kDa (1), Of potential interest is the cytosolic protein which migrates at Da ( specific proteins occurs (Mackall et al., 1976) , one of which is a fatty-acid-binding protein which migrates as a 15 kDa species (Bernlohr et al., 1984) . Although there are two cysteine residues in the amino acid sequence of this protein, they are distant from )f inhibition of insulin-stimulated each other (Bernlohr et al., 1984) , which would not provide the arsenical behaves similarly to most stable arsenical-dithiol configuration (which is a five-or choice for identifying potential six-membered ring as occurs with PAO-lipoic acid; Webb, 1966 
